Trial Profile
Everolimus efficacy in patients with advanced luminal breast cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 May 2015
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications HER2 negative breast cancer
- Focus Therapeutic Use
- 08 May 2015 New trial record